Home » Note to Readers

Note to Readers

Nov 13, 2012
Premium

Due to the Thanksgiving holiday in the US, In Sequence will not publish next week. The next issue of the newsletter will go out to subscribers on Tuesday, Nov.27.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

Oct 22, 2014

Illumina Records 70 Percent Sequential Growth in NIPT Samples in Q3, Dismisses NIPT Arrays

Premium
Jul 29, 2014

Note to Readers

Premium
Jul 23, 2014

Sequenom to Launch VisibiliT for Average-Risk Pregnancies Outside US, Expand MaterniT21 Plus

Premium
Apr 30, 2014

Expert Group Publishes Guidelines for Evaluating Pathogenicity of Sequence Variants

Premium
May 13, 2014

Bio-Rad Aims to Launch GnuBio Sequencer within Two Years, Discloses Purchase Price of up to $110M

Premium
Oct 14, 2014

Battelle, Forensic Labs to Put NGS Technology through Its Paces for Human Identification

Premium

The Scan

This Week in Genome Research

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

To the Brink

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Just Like Your Old Pop

Researchers report that paternally inherited genes are more likely to be expressed in mice.

This Week in PNAS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

What's Popular?

In Clinical Sequencing

  1. Baylor Aims to Boost Dx Rate, Discovery with 'Medical Exome,' Consenting Unsolved Cases for Research

    Premium

  2. Sequenom Posts 13 Percent Rise in Q4 Revenues, Reports Profitability for FY 2014

  3. AGBT: WashU Applies Genomic Testing to Predict Cancer Relapse, Drug Response, Vaccine Epitopes

    Premium

  4. At ACMG, Presenters Discuss False-Positive, False-Negative NIPT Results

  5. Qiagen Acquires Enzymatics, Inks Partnership with ArcherDX

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.